Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,001 | 15 | 97.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $16.80 | 1 | 1.6% |
| Travel and Lodging | $12.06 | 1 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $506.32 | 7 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $161.20 | 1 | $0 (2022) |
| Solta Medical, a division of Bausch Health US, LLC | $156.64 | 1 | $0 (2024) |
| Galderma Laboratories, L.P. | $128.77 | 3 | $0 (2024) |
| Allergan Inc. | $35.00 | 3 | $0 (2018) |
| Ocular Therapeutix, Inc. | $28.92 | 1 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $13.30 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $694.24 | 10 | ABBVIE INC. ($408.83) |
| 2022 | $287.61 | 3 | Bausch & Lomb Americas Inc. ($161.20) |
| 2020 | $13.30 | 1 | Janssen Pharmaceuticals, Inc ($13.30) |
| 2018 | $11.42 | 1 | Allergan Inc. ($11.42) |
| 2017 | $23.58 | 2 | Allergan Inc. ($23.58) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | Solta Medical, a division of Bausch Health US, LLC | CLEAR+BRILLIANT | Food and Beverage | In-kind items and services | $156.64 | General |
| 11/08/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $16.80 | General |
| 10/24/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $82.92 | General |
| 10/24/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $26.92 | General |
| 09/05/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $127.89 | General |
| 08/27/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $214.11 | General |
| 08/27/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $12.06 | General |
| 08/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: FACIAL AESTHETICS | ||||||
| 05/17/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $15.79 | General |
| 04/19/2024 | Galderma Laboratories, L.P. | DYSPORT (Biological) | Food and Beverage | In-kind items and services | $18.93 | General |
| 06/15/2022 | Bausch & Lomb Americas Inc. | LOTEMAX SM (Drug) | Food and Beverage | In-kind items and services | $161.20 | General |
| Category: Ophthalmology | ||||||
| 04/23/2022 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Food and Beverage | In-kind items and services | $28.92 | General |
| Category: Corticosteroid intracanalicular insert | ||||||
| 02/23/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $97.49 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/02/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/30/2017 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $11.55 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/26/2017 | Allergan Inc. | TAZORAC (Drug) | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 202 | 284 | $102,270 | $25,888 |
| 2022 | 1 | 91 | 97 | $44,835 | $14,470 |
| 2021 | 3 | 116 | 124 | $61,750 | $17,076 |
| 2020 | 2 | 112 | 114 | $141,032 | $18,885 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 70 | 70 | $41,510 | $9,207 | 22.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 64 | 64 | $23,416 | $6,203 | 26.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 36 | 98 | $20,580 | $5,872 | 28.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 13 | 32 | $9,504 | $2,916 | 30.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 19 | 20 | $7,260 | $1,690 | 23.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 91 | 97 | $44,835 | $14,470 | 32.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 83 | 84 | $46,639 | $12,957 | 27.8% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 15 | 15 | $7,686 | $2,161 | 28.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 18 | 25 | $7,425 | $1,958 | 26.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 95 | 96 | $115,832 | $15,610 | 13.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 17 | 18 | $25,200 | $3,276 | 13.0% |
About Dr. Michael Lindley, M.D
Dr. Michael Lindley, M.D is a Procedural Dermatology healthcare provider based in New Orleans, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2010. The National Provider Identifier (NPI) number assigned to this provider is 1811216807.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Lindley, M.D has received a total of $1,030 in payments from pharmaceutical and medical device companies, with $694.24 received in 2024. These payments were reported across 17 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($1,001).
As a Medicare-enrolled provider, Lindley has provided services to 521 Medicare beneficiaries, totaling 619 services with total Medicare billing of $76,319. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Procedural Dermatology
- Other Specialties Internal Medicine
- Location New Orleans, LA
- Active Since 05/31/2010
- Last Updated 10/16/2025
- Taxonomy Code 207NS0135X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1811216807
Products in Payments
- LOTEMAX SM (Drug) $161.20
- CLEAR+BRILLIANT $156.64
- VRAYLAR (Drug) $97.49
- DEXTENZA (Drug) $28.92
- BOTOX (Biological) $22.18
- DYSPORT (Biological) $18.93
- XARELTO (Drug) $13.30
- TAZORAC (Drug) $12.03
- TEFLARO (Drug) $11.55
- AVYCAZ (Drug) $11.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.